Abuse-related effects of dual dopamine/serotonin releasers with varying potency to release norepinephrine in male rats and rhesus monkeys

Experimental and Clinical Psychopharmacology

Volumn 22, Issue 3, 2014, Pages 274-284

  Banks, Matthew L ^a   Bauer, Clayton T ^a   Blough, Bruce E ^b   Rothman, Richard B ^c   Partilla, John S ^c   Baumann, Michael H ^c   Stevens Negus, S ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b RTI INTERNATIONAL   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Abuse related effects; Choice; Cocaine; D amphetamine; Dopamine; Monkeys; Norepinephrine; Rats; Serotonin

Indexed keywords

1 (1H INDOL 1 YL)PROPAIN 2 AMINE; 1 (1H INDOL 5YL)PROPAN 2 AMINE; 1 (5 FLUORO 1H INDOL 3 YL)PROPAN 2 AMINE; COCAINE; DEXAMPHETAMINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; FENFLURAMINE; NORADRENALIN; PAL 287; PAL 542; PAL 544; PAL 569; PAL 571; SEROTONIN; SEROTONIN AGONIST; UNCLASSIFIED DRUG; [1 (5 CHLORO 1H INDOL 3YL)PROPAN 2 AMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEPTH STIMULATION; COMPARATIVE STUDY; DISCRIMINATIVE STIMULUS; DOPAMINE RELEASE; DRUG ABUSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; EXPERIMENTAL MONKEY; FOOD INTAKE; IN VITRO STUDY; INTRACRANIAL SELF STIMULATION; MALE; NONHUMAN; RAT; SELF STIMULATION; SEROTONIN RELEASE; SINGLE DRUG DOSE; ADDICTION; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; INSTRUMENTAL CONDITIONING; METABOLISM; PHYSIOLOGY; PSYCHOLOGY; RHESUS MONKEY; SECRETION (PROCESS); SPECIES DIFFERENCE; SPRAGUE DAWLEY RAT;

ANIMALS; COCAINE; CONDITIONING, OPERANT; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MACACA MULATTA; MALE; NOREPINEPHRINE; RATS, SPRAGUE-DAWLEY; SEROTONIN; SPECIES SPECIFICITY; SUBSTANCE-RELATED DISORDERS;

EID: 84901825209     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0036595     Document Type: Article

References (47)

1. Anderson, K. G., Winger, G., Woods, J., & Woolverton, W. L. (2001). Reinforcing and discriminative-stimulus effects of ephedrine isomers in rhesus monkeys. Drug and Alcohol Dependence, 65, 45-53. doi: 10.1016/S0376-8716(01)00143-0.
2. Banks, M. L., Blough, B. E., Fennell, T. R., Snyder, R. W., & Negus, S. S. (2013a). Effects of phendimetrazine treatment on cocaine vs food choice and extended-access cocaine consumption in rhesus monkeys. Neuropsychopharmacology, 38, 2698-2707. doi:10.1038/npp.2013.180.
3. Banks, M. L., Blough, B. E., Fennell, T. R., Snyder, R. W., & Negus, S. S. (2013b). Role of phenmetrazine as an active metabolite of phendimetrazine: Evidence from studies of drug discrimination and pharmacokinetics in rhesus monkeys. Drug and Alcohol Dependence, 130, 158-166. doi:10.1016/j.drugalcdep.2012.10.026.
4. Banks, M. L., Blough, B. E., & Negus, S. S. (2011). Effects of monoamine releasers with varying selectivity for releasing dopamine/norepinephrine versus serotonin on choice between cocaine and food in rhesus monkeys. Behavioural Pharmacology, 22, 824-836. doi:10.1097/FBP.0b013e32834d63ac.
5. Banks, M. L., Blough, B. E., & Negus, S. S. (2013). Effects of 14-day treatment with the schedule III anorectic phendimetrazine on choice between cocaine and food in rhesus monkeys. Drug and Alcohol Dependence, 131, 204-213. doi:10.1016/j.drugalcdep.2013.05.005.
6. Banks, M. L., & Negus, S. S. (2012). Preclinical determinants of drug choice under concurrent schedules of drug self-administration. Advances in Pharmacological Sciences, 2012, 17 pp. doi:10.1155/2012/281768.
7. Bauer, C. T., Banks, M. L., Blough, B. E., & Negus, S. S. (2013). Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats. British Journal of Pharmacology, 168, 850-862. doi:10.1111/j.1476-5381.2012.02214.x.
8. Baumann, M. H., Ayestas, M. A., Partilla, J. S., Sink, J. R., Shulgin, A. T., Daley, P. F., Cozzi, N. V. (2012). The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology, 37, 1192-1203. doi:10.1038/npp.2011.304.
9. Baumann, M. H., Clark, R. D., Woolverton, W. L., Wee, S., Blough, B. E., & Rothman, R. B. (2011). In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the tat. The Journal of Pharmacology and Experimental Therapeutics, 337, 218-225. doi:10.1124/jpet.110.176271.
10. Broadbent, J., Michael, E. K., Riddle, E. E., & Apple, J. B. (1991). Involvement of dopamine uptake in the discriminative stimulus effects of cocaine. Behavioural Pharmacology, 2, 187-198. doi:10.1097/00008877-199106000-00002.
11. 2-like agonists in rats trained to discriminate cocaine from saline: Influence of experimental history. Experimental and Clinical Psychopharmacology, 8, 404-414. doi:10.1037/1064-1297.8.3.404.
12. Carlezon, W. A., & Chartoff, E. H. (2007). Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation. Nature Protocols, 2, 2987-2995. http://www.nature.com/nprot/journal/v2/n11/suppinfo/nprot.2007.441_S1.html.
13. Chiodo, K. A., Läck, C. M., & Roberts, D. C. S. (2008). Cocaine selfadministration reinforced on a progressive ratio schedule decreases with continuous d-amphetamine treatment in rats. Psychopharmacology, 200, 465-473. doi:10.1007/s00213-008-1222-8.
14. Czoty, P. W., Gould, R. W., Martelle, J. L., & Nader, M. A. (2011). Prolonged attenuation of the reinforcing strength of cocaine by chronic d-amphetamine in rhesus monkeys. Neuropsychopharmacology, 36, 539-547. doi:10.1038/npp.2010.185.
15. Elder, S. T., Montgomery, N. P., & Rye, M. M. (1965). Effects of food deprivation and methamphetamine on fixed-ratio schedules if intracranial self-stimulation. Psychological Reports, 16, 1225-1233. doi: 10.2466/pr0.1965.16.3c.1225.
16. Gold, L. H., & Balster, R. L. (1996). Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil. Psychopharmacology, 126, 286-292. doi:10.1007/BF02247379.
17. Grabowski, J., Rhoades, H., Schmitz, J., Stotts, A., Daruzska, L. A., Creson, D., & Moeller, F. G. (2001). Dextroamphetamine for cocainedependence treatment: A double-blind randomized clinical trial. Journal of Clinical Psychopharmacology, 21, 522-526. doi:10.1097/00004714-200110000-00010.
18. Grabowski, J., Rhoades, H., Stotts, A., Cowan, K., Kopecky, C., Dougherty, A., Schmitz, J. (2004). Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: Two double-blind randomized clinical trials. Neuropsychopharmacology, 29, 969-981. doi:10.1038/sj.npp.1300392.
19. Grabowski, J., Shearer, J., Merrill, J., & Negus, S. S. (2004). Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence. Addictive Behaviors, 29, 1439-1464. doi:10.1016/j.addbeh.2004.06.018.
20. Greenwald, M. K., Lundahl, L. H., & Steinmiller, C. L. (2010). Sustained release d-amphetamine reduces cocaine but not "speedball"-seeking in buprenorphine-maintained volunteers: A test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers. Neuropsychopharmacology, 35, 2624-2637. doi:10.1038/npp.2010.175.
21. Hall, F. S., Stellar, J. R., & Kelley, A. E. (1990). Acute and chronic desipramine treatment effects on rewarding electrical stimulation of the lateral hypothalamus. Pharmacology Biochemistry and Behavior, 37, 277-281. doi:10.1016/0091-3057(90)90334-E.
22. Kamien, J. B., & Woolverton, W. L. (1989). A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics, 248, 938-946.
23. Kampman, K. M., Rukstalis, M., Pettinati, H., Muller, E., Acosta, T., Gariti, P., O'Brien, C. P. (2000). The combination of phentermine and fenfluramine reduced cocaine withdrawal symptoms in an open trial. Journal of Substance Abuse Treatment, 19, 77-79. doi:10.1016/S0740-5472(99)00076-8.
24. Kantak, K. M., Edwards, M. A., & Spealman, R. D. (1995). Effects of N-methyl-D-aspartate antagonists in rats discriminating different doses of cocaine: Comparison with direct and indirect dopamine agonists. The Journal of Pharmacology and Experimental Therapeutics, 274, 657-665.
25. Kimmel, H. L., Negus, S. S., Wilcox, K. M., Ewing, S. B., Stehouwer, J., Goodman, M. M., & Howell, L. L. (2008). Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeys. Pharmacology, Biochemistry, and Behavior, 90, 453-462. doi:10.1016/j.pbb.2008.03.032.
26. Kleven, M. S., Anthony, E. W., & Woolverton, W. L. (1990). Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics, 254, 312-317.
27. Lamas, X., Negus, S. S., Hall, E., & Mello, N. K. (1995). Relationship between the discriminative stimulus effects and plasma concentrations of intramuscular cocaine in rhesus monkeys. Psychopharmacology, 121, 331-338. doi:10.1007/BF02246072.
28. Mooney, M. E., Herin, D. V., Schmitz, J. M., Moukaddam, N., Green, C. E., & Grabowski, J. (2009). Effects of oral methamphetamine on cocaine use: A randomized, double-blind, placebo-controlled trial. Drug and Alcohol Dependence, 101, 34-41. doi:10.1016/j.drugalcdep.2008.10.016.
29. Nader, M. A., & Woolverton, W. (1991). Effects of increasing the magnitude of an alternative reinforcer on drug choice in a discrete-trials choice procedure. Psychopharmacology, 105, 169-174. doi:10.1007/BF02244304.
30. Negus, S. S. (2003). Rapid assessment of choice between cocaine and food in rhesus monkeys: Effects of environmental manipulations and treatment with d-amphetamine and flupenthixol. Neuropsychopharmacology, 28, 919-931.
31. Negus, S. S., Mello, N. K., Blough, B. E., Baumann, M. H., & Rothman, R. B. (2007). Monoamine releasers with varying selectivity for dopamine/norepinephrine versus serotonin release as candidate "agonist" medications for cocaine dependence: Studies in assays of cocaine discrimination and cocaine self-administration in rhesus monkeys. The Journal of Pharmacology and Experimental Therapeutics, 320, 627-636. doi:10.1124/jpet.106.107383.
32. Olds, M. E. (1995). Dopamine agonists prevent or counteract the suppression of brain stimulation reward by fenfluramine. Pharmacology, Biochemistry, and Behavior, 50, 41-48. doi:10.1016/0091-3057(94)00240-J.
33. Risner, M., & Jones, B. E. (1976). Role of noradrenergic and dopaminergic processes in amphetamine self-administration. Pharmacology Biochemistry and Behavior, 5, 477-482. doi:10.1016/0091-3057(76)90113-1.
34. Robinson, J. E., Agoglia, A. E., Fish, E. W., Krouse, M. C., & Malanga, C. J. (2012). Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: Comparison to cocaine. Behavioural Brain Research, 234, 76-81. doi:10.1016/j.bbr.2012.06.012.
35. Rosenberg, M. B., Carroll, F. I., & Negus, S. S. (2013). Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats. Journal of Pain, 14, 246-259. doi: 10.1016/j.jpain.2012.11.006.
36. Rothman, R. B., Baumann, M. H., Dersch, C. M., Romero, D. V., Rice, K. C., Carroll, F. I., & Partilla, J. S. (2001). Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse, 39, 32-41. doi:10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3.
37. Rothman, R. B., Blough, B. E., & Baumann, M. H. (2008). Dopamine/serotonin releasers as medications for stimulant addictions. Prog Brain Res 172, 385-406.
38. Rothman, R. B., Blough, B. E., Woolverton, W. L., Anderson, K. G., Negus, S. S., Mello, N. K., & Baumann, M. H. (2005). Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration. The Journal of Pharmacology and Experimental Therapeutics, 313, 1361-1369. doi:10.1124/jpet.104.082503.
39. Rush, C. R., Stoops, W. W., Sevak, R. J., & Hays, L. R. (2010). Cocaine choice in humans during D-amphetamine maintenance. Journal of Clinical Psychopharmacology, 30, 152-159. doi:10.1097/JCP.0b013e3181d21967.
40. Schechter, M. D. (1997). Discriminative characteristics of high and low cocaine administration: Effect of other psychostimulants. Pharmacology Biochemistry and Behavior, 56, 457-463. doi:10.1016/S0091-3057(96)00301-2.
41. Stoops, W. W., & Rush, C. R. (2013). Agonist replacement for stimulant dependence: A review of clinical research. Current Pharmaceutical Design, 19, 7026-7035. doi:10.2174/138161281940131209142843.
42. Terry, P., Witkin, J. M., & Katz, J. L. (1994). Pharmacological characterization of the novel discriminative stimulus effects of a low dose of cocaine. The Journal of Pharmacology and Experimental Therapeutics, 270, 1041-1048.
43. Thomsen, M., Barrett, A. C., Negus, S. S., & Caine, S. B. (2013). Cocaine versus food choice procedure in rats: Environmental manipulations and effects of amphetamine. Journal of the Experimental Analysis of Behavior, 99, 211-233. doi:10.1002/jeab.15.
44. Tongjaroenbuangam, W., Meksuriyen, D., Govitrapong, P., Kotchabhakdi, N., & Baldwin, B. A. (1998). Drug discrimination analysis of pseudoephedrine in rats. Pharmacology Biochemistry and Behavior, 59, 505-510. doi:10.1016/S0091-3057(97)00459-0.
45. Wee, S., Anderson, K. G., Baumann, M. H., Rothman, R. B., Blough, B. E., & Woolverton, W. L. (2005). Relationship between the serotonergic activity and reinforcing effects of a series of amphetamine analogs. The Journal of Pharmacology and Experimental Therapeutics, 313, 848-854.
46. Weerts, E. M., Fantegrossi, W. E., & Goodwin, A. K. (2007). The value of nonhuman primates in drug abuse research. Experimental Clinical Psychopharmacology, 15, 309-327.
47. Woolverton, W. L. (1987). Evaluation of the role of norepinephrine in the reinforcing effects of psychomotor stimulants in rhesus monkeys. Pharmacology Biochemistry and Behavior, 26, 835-839.